Advisory - Duchesnay Inc. recalls certain lots of PregVit and PregVit folic 5 prenatal and postpartum vitamin-mineral supplements because of a packaging error
OTTAWA, Nov. 15, 2019 /CNW/ - Health Canada is advising Canadians that Duchesnay Inc. is recalling certain lots of PregVit vitamin-mineral supplements (for prenatal and postpartum use) and PregVit folic 5 vitamin-mineral supplements (for prenatal use) because blister packages may contain all pink (morning) tablets instead of the correct combination of pink and blue (evening) tablets. The company estimates the issue affects a very small number of products in certain lots (see the table below) and not all products.
There are no quality, safety or effectiveness concerns with the tablets themselves but there is the potential that patients may not take the proper combination of pink and blue tablets if they have received products impacted by the packaging error.
The pink and the blue tablets do not contain the same active ingredients. Women taking all pink tablets will not receive the intended vitamin and mineral supplements. In particular, the pink tablets do not contain folic acid, which is important for the healthy growth of an unborn baby and helps to reduce some types of birth defects called neural tube defects.
Properly packaged products should contain two blister packs, with each blister pack containing 15 pink tablets and 15 blue tablets. The company received a complaint of a product containing a blister pack that contained all pink tablets and no blue tablets.
Who is affected Women who have bought or are using the affected products.
Affected products
Product
DIN
Lot
Expiry
PregVit
Format 60
02451573
19003
2021-10-31
19001V
2021-09-30
18015V
2021-08-31
18010V
2021-05-31
18012V
2021-04-30
18006V
2020-08-31
18003V
2020-06-30
17019V
2020-05-31
17016
2020-07-31
17002
2020-03-31
16065
2020-02-29
16064
2020-01-31
16045
2019-12-31
16042
2019-12-31
PregVit folic 5
Format 60
02451581
18022
2021-07-31
18007
2020-10-31
18002
2020-09-30
16053
2019-12-31
What consumers should do
Check your product to make sure it contains the correct combination of pink and blue tablets (each blister pack should contain 15 pink and 15 blue tablets [see photos]).
Continue taking the prescribed number of pink and blue tablets per day as directed by your health care professional. If your product has an incorrect tablet combination, talk to your pharmacist about obtaining a replacement. Properly packaged products do not need to be returned.
Consult your health care professional if you have used either of these products and have health concerns.
Contact Duchesnay Inc. by calling toll-free at 1-888-666-0611, or by email at [email protected], if you have any questions about the recall.
Check packages of PregVit and PregVit folic 5 before dispensing them to patients.
Not all lots are being recalled. While the company has put a verification process in place to make sure that products not impacted by this recall are properly packaged, checking products before dispensing provides an added safeguard.
What Health Canada is doing Health Canada is monitoring the recall and verifying that the company has effectively addressed the packaging issue. Should additional safety concerns be identified, Health Canada will take appropriate action and inform Canadians as necessary.
The "Global Immunoprecipitation Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029" report has been added to ResearchAndMarkets.com's offering.
The Global Immunoprecipitation Testing Market size is estimated...
Regulatory News:
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and...
Mishe (say "mish-e"), an innovator in direct healthcare, announces the launch of Downstate's Transparent Access Plan, making SUNY Downstate Health Sciences University the first hospital system in the US to offer transparent upfront pricing for its...
Susan G. Komen®, the world's leading breast cancer organization commends the State Assembly's proposed funding increase of $2.5 million for the Cancer Services Program (CSP) in the FY2025 Budget....
Neuroscientists have established in recent decades the idea that some of each day's experiences are converted by the brain into permanent memories during sleep the same night. Now, a new study proposes a mechanism that determines which memories are...
While traditional diaper rash creams are thick, sticky, and messy, Taro's new bébé Bottoms Diaper Rash Crème Spray allows for easy, one-handed application of a gentle spray formula that is touch-free with no rubbing needed. The light spray, which...